A survey of the mechanisms of action of anticancer transition metal complexes.

about

On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imaging.

P2860

Q39399932-DD85E8BD-D4D3-4465-970F-97AE81AE70D2

P2860

A survey of the mechanisms of action of anticancer transition metal complexes.

Item

http://www.wikidata.org/entity/Q38792102

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A survey of the mechanisms of action of anticancer transition metal complexes.

@en

type

Item

label

A survey of the mechanisms of action of anticancer transition metal complexes.

@en

prefLabel

A survey of the mechanisms of action of anticancer transition metal complexes.

@en

P1476

A survey of the mechanisms of action of anticancer transition metal complexes.

@en

P2093

François Dufrasne

http://www.w3.org/2001/XMLSchema#string

Gilles Berger

http://www.w3.org/2001/XMLSchema#string

Michel Gelbcke

http://www.w3.org/2001/XMLSchema#string

Mickaël Marloye

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

Toxicogenomic effect of nickel and beyond

A review of molecular events of cadmium-induced carcinogenesis

Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo

Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles

Effects of terminal dimethylation and metal coordination of proline-2-formylpyridine thiosemicarbazone hybrids on lipophilicity, antiproliferative activity, and hR2 RNR inhibition.

Structural Determinants of Cisplatin and Transplatin Binding to the Met-Rich Motif of Ctr1: A Computational Spectroscopy Approach.

The first iron(III) complexes with cyclin-dependent kinase inhibitors: Magnetic, spectroscopic (IR, ES+ MS, NMR, (57)Fe Mössbauer), theoretical, and biological activity studies.

Mo(II) complexes: a new family of cytotoxic agents?

P304

2263-2286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC-2016-0153

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27874280

http://www.w3.org/2001/XMLSchema#string

P921

Auergungsmetal

A survey of the mechanisms of action of anticancer transition metal complexes.

about

P2860

P2860

A survey of the mechanisms of action of anticancer transition metal complexes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921